HeartSciences is focused on applying innovative AI-based technology to an ECG.
Location: United States, Texas, Southlake
Employees: 11-50
Phone: +1 737-414-9213
Founded date: 2008
Investors 1
| Date | Name | Website |
| 10.07.2026 | SWPDC | swpdc.org/ |
Mentions in press and media 7
| Date | Title | Description |
| 12.03.2024 | HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes | - |
| 06.03.2024 | HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology | - |
| 21.08.2023 | HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio | European Patent Allowed for Quantification by an ECG of Key Heart Measures using AI Heart Test Laboratories, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier de... |
| 10.05.2023 | HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG | Heart Test Laboratories, d/b/a HeartSciences (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the early detection of heart disease, ... |
| 06.02.2023 | HeartSciences Granted Key Israeli International Patent for its MyoVista Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease | Heart Test Laboratories, . d/b/a HeartSciences, a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), announced it ha... |
| 24.01.2023 | Q4 Was Digital Health’s Worst Quarter for Funding in 5 Years | In 2020 and 2021, investors were taking risks amid low interest rates and there was a mammoth influx of investment dollars into startups. They were willing to pay more amid high valuations to get a piece of innovative healthcare businesses.... |
| 13.11.2022 | HeartSciences’ MyoVista Technology Used to Develop AI-ECG Algorithm to Identify Patients | Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification Heart Test Laboratories, d/b/a HeartSciences , a medical technology company focused on saving lives by m... |